Loading company…
smartbax develops antibiotics targeting drug-resistant bacterial infections.
Founded in 2021 and based in Germany, smartbax is a biotechnology company developing antibiotics for bacterial infections. Its research targets drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. The company also aims to expand its scientific team to advance its research platforms.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in